| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 12 | 2024 | 90 | 6.180 |
Why?
|
| Adenoviridae | 17 | 2024 | 610 | 5.260 |
Why?
|
| Oncolytic Viruses | 9 | 2024 | 77 | 4.060 |
Why?
|
| Immunotherapy, Adoptive | 9 | 2024 | 886 | 2.480 |
Why?
|
| Genetic Vectors | 15 | 2020 | 970 | 2.300 |
Why?
|
| Fukushima Nuclear Accident | 2 | 2025 | 2 | 1.770 |
Why?
|
| Soil Pollutants, Radioactive | 2 | 2025 | 4 | 1.770 |
Why?
|
| Radiation Monitoring | 2 | 2025 | 16 | 1.760 |
Why?
|
| Neoplasms | 8 | 2024 | 3028 | 1.660 |
Why?
|
| Transgenes | 9 | 2015 | 346 | 1.550 |
Why?
|
| Amino Acids | 4 | 2025 | 687 | 1.550 |
Why?
|
| Genetic Therapy | 10 | 2023 | 733 | 1.520 |
Why?
|
| Antibodies, Bispecific | 2 | 2024 | 51 | 1.450 |
Why?
|
| Serine | 5 | 2024 | 185 | 1.400 |
Why?
|
| Cesium Radioisotopes | 3 | 2025 | 8 | 1.380 |
Why?
|
| T-Lymphocytes | 8 | 2024 | 1810 | 1.250 |
Why?
|
| Soil | 3 | 2025 | 72 | 1.230 |
Why?
|
| Insect Proteins | 2 | 2025 | 111 | 1.120 |
Why?
|
| Interleukin-12 | 4 | 2021 | 122 | 1.110 |
Why?
|
| Helper Viruses | 5 | 2021 | 46 | 1.010 |
Why?
|
| Sex Determination Processes | 2 | 2025 | 13 | 0.990 |
Why?
|
| Food Contamination, Radioactive | 1 | 2025 | 1 | 0.980 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2024 | 500 | 0.970 |
Why?
|
| Oryza | 1 | 2025 | 29 | 0.950 |
Why?
|
| Moths | 1 | 2024 | 25 | 0.920 |
Why?
|
| Sarcoidosis | 2 | 2022 | 59 | 0.890 |
Why?
|
| Composting | 1 | 2023 | 1 | 0.870 |
Why?
|
| Simplexvirus | 3 | 2009 | 107 | 0.860 |
Why?
|
| Immunity, Innate | 6 | 2025 | 416 | 0.840 |
Why?
|
| B7-H1 Antigen | 4 | 2021 | 129 | 0.830 |
Why?
|
| Janus Kinases | 1 | 2023 | 33 | 0.810 |
Why?
|
| Animals | 40 | 2025 | 36416 | 0.790 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2024 | 1006 | 0.790 |
Why?
|
| Combined Modality Therapy | 4 | 2024 | 1308 | 0.760 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2015 | 101 | 0.760 |
Why?
|
| Alanine | 1 | 2022 | 189 | 0.730 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 294 | 0.700 |
Why?
|
| Myocarditis | 1 | 2022 | 137 | 0.690 |
Why?
|
| Aortic Valve Stenosis | 2 | 2021 | 360 | 0.680 |
Why?
|
| Ecosystem | 1 | 2021 | 110 | 0.670 |
Why?
|
| Mice | 31 | 2025 | 18944 | 0.670 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2020 | 21 | 0.670 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 165 | 0.620 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 112 | 0.610 |
Why?
|
| Receptor, ErbB-2 | 6 | 2024 | 559 | 0.600 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 1068 | 0.600 |
Why?
|
| Cisplatin | 1 | 2019 | 287 | 0.570 |
Why?
|
| Dependovirus | 4 | 2021 | 151 | 0.570 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 557 | 0.570 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2017 | 801 | 0.560 |
Why?
|
| Gene Silencing | 2 | 2010 | 247 | 0.550 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 241 | 0.550 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2021 | 872 | 0.510 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3754 | 0.510 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 701 | 0.480 |
Why?
|
| Stereoisomerism | 5 | 2025 | 119 | 0.480 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2015 | 4 | 0.480 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 538 | 0.480 |
Why?
|
| Kidney Diseases | 1 | 2019 | 505 | 0.470 |
Why?
|
| Chromatin | 4 | 2024 | 612 | 0.460 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 732 | 0.460 |
Why?
|
| Glycolysis | 1 | 2015 | 172 | 0.450 |
Why?
|
| Japan | 2 | 2025 | 155 | 0.430 |
Why?
|
| Factor X | 1 | 2012 | 4 | 0.410 |
Why?
|
| Gene Expression | 5 | 2017 | 1616 | 0.400 |
Why?
|
| Humans | 38 | 2025 | 133547 | 0.390 |
Why?
|
| Escherichia coli Infections | 2 | 2025 | 187 | 0.390 |
Why?
|
| Interferon Type I | 1 | 2013 | 115 | 0.390 |
Why?
|
| Astrocytes | 1 | 2015 | 272 | 0.380 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2011 | 23 | 0.360 |
Why?
|
| Liver | 7 | 2025 | 1878 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4841 | 0.350 |
Why?
|
| Gene Transfer Techniques | 5 | 2021 | 365 | 0.340 |
Why?
|
| Histones | 2 | 2024 | 568 | 0.320 |
Why?
|
| Signal Transduction | 3 | 2024 | 4908 | 0.320 |
Why?
|
| Herpesvirus 1, Human | 2 | 2008 | 34 | 0.320 |
Why?
|
| Male | 18 | 2025 | 65791 | 0.310 |
Why?
|
| Hippocampus | 1 | 2015 | 863 | 0.310 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2013 | 248 | 0.310 |
Why?
|
| Aortic Valve | 3 | 2021 | 468 | 0.310 |
Why?
|
| Female | 17 | 2025 | 71537 | 0.310 |
Why?
|
| Mice, Knockout | 10 | 2024 | 3991 | 0.300 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 690 | 0.300 |
Why?
|
| Immediate-Early Proteins | 1 | 2009 | 60 | 0.300 |
Why?
|
| Tumor Burden | 2 | 2021 | 257 | 0.300 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 292 | 0.300 |
Why?
|
| Inflammation | 3 | 2025 | 1591 | 0.290 |
Why?
|
| Heart Failure | 1 | 2021 | 2423 | 0.280 |
Why?
|
| Transduction, Genetic | 4 | 2016 | 296 | 0.280 |
Why?
|
| STAT1 Transcription Factor | 1 | 2007 | 78 | 0.270 |
Why?
|
| Cytokines | 4 | 2025 | 1396 | 0.270 |
Why?
|
| Mammals | 3 | 2025 | 280 | 0.260 |
Why?
|
| Dendritic Cells | 2 | 2024 | 447 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2009 | 389 | 0.250 |
Why?
|
| Bombyx | 1 | 2025 | 3 | 0.240 |
Why?
|
| Plasmids | 1 | 2006 | 526 | 0.230 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2025 | 36 | 0.230 |
Why?
|
| Receptors, Serotonin | 1 | 2024 | 45 | 0.230 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 24 | 0.230 |
Why?
|
| Chorioallantoic Membrane | 1 | 2024 | 12 | 0.230 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2024 | 6 | 0.220 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 1756 | 0.220 |
Why?
|
| Clinical Studies as Topic | 2 | 2021 | 10 | 0.220 |
Why?
|
| Immunoglobulin A | 2 | 2024 | 219 | 0.220 |
Why?
|
| CD3 Complex | 1 | 2024 | 93 | 0.220 |
Why?
|
| Liver Abscess | 1 | 2023 | 13 | 0.220 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2024 | 40 | 0.220 |
Why?
|
| Cesium | 1 | 2023 | 15 | 0.220 |
Why?
|
| Manure | 1 | 2023 | 6 | 0.220 |
Why?
|
| Fertilizers | 1 | 2023 | 5 | 0.220 |
Why?
|
| RNA Splicing | 1 | 2025 | 251 | 0.210 |
Why?
|
| Mice, Inbred NOD | 2 | 2024 | 318 | 0.210 |
Why?
|
| Serotonin | 1 | 2024 | 226 | 0.210 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 22 | 0.210 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 25 | 0.200 |
Why?
|
| Blastocyst | 1 | 2023 | 79 | 0.200 |
Why?
|
| RNA Interference | 1 | 2024 | 544 | 0.200 |
Why?
|
| ErbB Receptors | 1 | 2004 | 303 | 0.200 |
Why?
|
| Plants | 1 | 2022 | 52 | 0.190 |
Why?
|
| Cattle | 1 | 2023 | 587 | 0.190 |
Why?
|
| D-Amino-Acid Oxidase | 2 | 2019 | 3 | 0.190 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2022 | 25 | 0.190 |
Why?
|
| Symbiosis | 1 | 2023 | 101 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 315 | 0.190 |
Why?
|
| Mice, Nude | 3 | 2017 | 777 | 0.190 |
Why?
|
| Adaptive Immunity | 2 | 2015 | 97 | 0.190 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 106 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2024 | 745 | 0.190 |
Why?
|
| Proline | 1 | 2022 | 80 | 0.190 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 355 | 0.180 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 171 | 0.180 |
Why?
|
| A549 Cells | 2 | 2021 | 49 | 0.180 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 31 | 0.180 |
Why?
|
| Interferon-alpha | 1 | 2023 | 248 | 0.180 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 136 | 0.180 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2022 | 88 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2022 | 364 | 0.180 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 45 | 0.170 |
Why?
|
| Retrospective Studies | 5 | 2022 | 17401 | 0.170 |
Why?
|
| Intestines | 2 | 2024 | 615 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 614 | 0.170 |
Why?
|
| Coculture Techniques | 1 | 2021 | 246 | 0.170 |
Why?
|
| Histone Deacetylases | 2 | 2013 | 123 | 0.170 |
Why?
|
| Amino Acid Sequence | 1 | 2024 | 2789 | 0.170 |
Why?
|
| Viral Tropism | 2 | 2021 | 53 | 0.170 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2019 | 7 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 310 | 0.160 |
Why?
|
| Hyaluronan Receptors | 1 | 2020 | 68 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 154 | 0.160 |
Why?
|
| Sinus of Valsalva | 1 | 2020 | 35 | 0.160 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2019 | 8 | 0.160 |
Why?
|
| Dysbiosis | 1 | 2021 | 145 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 1046 | 0.160 |
Why?
|
| Molecular Sequence Data | 1 | 2024 | 3970 | 0.160 |
Why?
|
| Fibroblasts | 3 | 2010 | 921 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 174 | 0.150 |
Why?
|
| Mice, SCID | 1 | 2020 | 613 | 0.150 |
Why?
|
| RNA, Messenger | 3 | 2011 | 2898 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 211 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2021 | 219 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 745 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 567 | 0.140 |
Why?
|
| DNA Primers | 2 | 2009 | 669 | 0.140 |
Why?
|
| Antibodies, Neoplasm | 1 | 2017 | 60 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1782 | 0.140 |
Why?
|
| Lymphocyte Transfusion | 1 | 2017 | 58 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2020 | 483 | 0.140 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 97 | 0.130 |
Why?
|
| Heart | 1 | 2022 | 749 | 0.130 |
Why?
|
| Bacteria | 1 | 2021 | 534 | 0.130 |
Why?
|
| Aged | 5 | 2022 | 21637 | 0.130 |
Why?
|
| Antibody Formation | 2 | 2015 | 280 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 2163 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 1327 | 0.130 |
Why?
|
| DNA, Viral | 2 | 2009 | 501 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2173 | 0.130 |
Why?
|
| Brain | 1 | 2008 | 3225 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12997 | 0.120 |
Why?
|
| Serpins | 1 | 2015 | 34 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 7181 | 0.120 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 76 | 0.120 |
Why?
|
| Racemases and Epimerases | 1 | 2015 | 11 | 0.120 |
Why?
|
| NADP | 1 | 2015 | 55 | 0.120 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 64 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1850 | 0.120 |
Why?
|
| Mice, Inbred ICR | 1 | 2015 | 153 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2020 | 521 | 0.120 |
Why?
|
| Prognosis | 2 | 2021 | 5073 | 0.110 |
Why?
|
| Myocardium | 1 | 2020 | 1045 | 0.110 |
Why?
|
| Eye Proteins | 1 | 2015 | 233 | 0.110 |
Why?
|
| Factor VIII | 2 | 2012 | 48 | 0.110 |
Why?
|
| Base Sequence | 2 | 2009 | 3171 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 296 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2017 | 1596 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 496 | 0.110 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2015 | 167 | 0.100 |
Why?
|
| Bone and Bones | 1 | 2015 | 309 | 0.100 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2013 | 13 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 124 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 369 | 0.100 |
Why?
|
| Cell Line | 2 | 2010 | 2840 | 0.100 |
Why?
|
| Capsid | 1 | 2012 | 147 | 0.090 |
Why?
|
| Tomography | 2 | 2022 | 36 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 377 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2012 | 184 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2012 | 191 | 0.090 |
Why?
|
| Hemophilia A | 1 | 2011 | 24 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2015 | 395 | 0.090 |
Why?
|
| Genome, Viral | 1 | 2011 | 186 | 0.080 |
Why?
|
| Epigenomics | 1 | 2011 | 195 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 59 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 509 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 150 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 133 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 484 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 22 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2010 | 159 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 291 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2010 | 362 | 0.080 |
Why?
|
| Escherichia coli | 2 | 2025 | 1010 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2008 | 54 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2008 | 97 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1928 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2010 | 335 | 0.070 |
Why?
|
| Middle Aged | 4 | 2022 | 29254 | 0.070 |
Why?
|
| Aorta | 2 | 2022 | 559 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 866 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2008 | 92 | 0.070 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2021 | 87 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 1134 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2010 | 538 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 3173 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 836 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 549 | 0.070 |
Why?
|
| CD11b Antigen | 1 | 2007 | 39 | 0.070 |
Why?
|
| Vero Cells | 1 | 2007 | 113 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1535 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 1102 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 1339 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 697 | 0.060 |
Why?
|
| Luciferases | 1 | 2006 | 137 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2022 | 799 | 0.060 |
Why?
|
| Genes, Viral | 1 | 2006 | 186 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 1042 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2025 | 22 | 0.060 |
Why?
|
| Macrophages | 1 | 2010 | 703 | 0.060 |
Why?
|
| Gene Amplification | 1 | 2006 | 247 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 608 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1624 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 2024 | 43 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2024 | 32 | 0.060 |
Why?
|
| Enteric Nervous System | 1 | 2024 | 43 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2024 | 130 | 0.060 |
Why?
|
| Zygote | 1 | 2024 | 31 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 1356 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2004 | 121 | 0.050 |
Why?
|
| Morula | 1 | 2023 | 1 | 0.050 |
Why?
|
| Biological Transport | 1 | 2024 | 369 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2024 | 275 | 0.050 |
Why?
|
| Glioma | 1 | 2008 | 538 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2024 | 396 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2023 | 126 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2025 | 320 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2023 | 123 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 145 | 0.050 |
Why?
|
| Sodium | 1 | 2024 | 309 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2013 | 2712 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 2655 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2023 | 441 | 0.050 |
Why?
|
| Gene Editing | 1 | 2024 | 213 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2023 | 452 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 295 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 497 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 6581 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2023 | 222 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2025 | 476 | 0.040 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 9 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2023 | 676 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4791 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 276 | 0.040 |
Why?
|
| Flecainide | 1 | 2019 | 23 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 815 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 395 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2021 | 268 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 1079 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 190 | 0.040 |
Why?
|
| Virus Replication | 2 | 2015 | 637 | 0.040 |
Why?
|
| Kidney | 1 | 2024 | 1418 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2024 | 2025 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 2164 | 0.030 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 2015 | 2 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 104 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2015 | 49 | 0.030 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2015 | 20 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 130 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2015 | 48 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 85 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2015 | 76 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2657 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2297 | 0.030 |
Why?
|
| Lipocalins | 1 | 2014 | 30 | 0.030 |
Why?
|
| Lipocalin-2 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 50 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 645 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 1004 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2014 | 137 | 0.030 |
Why?
|
| Cystatin C | 1 | 2014 | 66 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 151 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 814 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3088 | 0.030 |
Why?
|
| Bone Density | 1 | 2015 | 374 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2012 | 46 | 0.020 |
Why?
|
| Antigens | 1 | 2012 | 157 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 445 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 429 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2012 | 321 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 76 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 824 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 444 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 746 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2011 | 22 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 122 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2011 | 40 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 215 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 382 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2012 | 391 | 0.020 |
Why?
|
| Interferon beta-1a | 1 | 2008 | 20 | 0.020 |
Why?
|
| Butyrates | 1 | 2008 | 42 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 905 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2008 | 240 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2008 | 168 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2008 | 147 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 11101 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4551 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 1198 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1439 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6294 | 0.010 |
Why?
|
| Melanoma | 1 | 2008 | 964 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31830 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 1407 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8588 | 0.010 |
Why?
|